HQL on NYSE

abrdn Life Sciences Investors

Abrdn Life Sciences Investors is an association registered in the United States, based in Boston, active since 1992.² Its shares trade on NYSE under the symbol HQL.²

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with another stock.

TickerHQL on NYSE²
HeadquartersBoston, United States²
Incorporated inMA³
Business address1900 Market Street, Suite 200, Philadelphia, Pa 19103³
Legal formVoluntary Association and Business Trusts²
Kind of organizationAssociation²
LEI5493007BYZPSOVVS0M04²
StatusActive²
LEI statusIssued and current²
Registered address28 STATE STREET, 17TH FLOOR, 02109 Boston, United States²
Registered withCorporations Division (Secretary of the Commonwealth's Office), T00386161²

See how the biggest companies compare on our leaderboards

Corporate structure

abrdn Life Sciences Investors sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of abrdn Life Sciences Investors

FIRST TRUST PORTFOLIOS LP Filed SCHEDULE 13G/A on abrdn Life Sciences Investors, latest Oct 14, 2026 (5 filings since Jan 21, 2022)
Saba Capital Management, L.P. Filed SCHEDULE 13D/A on abrdn Life Sciences Investors, latest Feb 23, 2026 (13 filings since Dec 29, 2023)

abrdn Life Sciences Investors Boston, Massachusetts, United States

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

Leadership

Who has led abrdn Life Sciences Investors, and when. Pick a name to see everywhere that person has worked.

President

Chief financial officer

Sharon Greenstein2023

2010201520202025

PresidentChristian Pittard Nov 6, 2023 to Nov 6, 2023⁴
PresidentDaniel R. Omstead Oct 2, 2006 to Sep 25, 2023⁵
Chief financial officerSharon Greenstein Nov 6, 2023 to Nov 6, 2023⁶

Board members and other officers (34)

Vice PresidentKatie Lynn Gebauer Mar 20, 2025 to now⁷
Vice PresidentMichael Marsico Mar 20, 2025 to now⁸
Vice PresidentRobert W. Hepp Mar 20, 2025 to now⁹
Vice PresidentHeather Carter Reilly Dec 19, 2025 to now¹⁰
Vice PresidentLoretta Tse Mar 22, 2024 to Mar 22, 2024¹¹
Vice PresidentMichael Taggart Jun 18, 2024 to now¹²
Vice PresidentAshton Wilson Dec 20, 2024 to Dec 20, 2024¹³
Vice PresidentKolotioloma Silue Dec 20, 2024 to Dec 20, 2024¹⁴
Vice PresidentAlan R. Goodson Nov 6, 2023 to Nov 6, 2023¹⁵
Chief Compliance Officer & VPJoseph Andolina Nov 6, 2023 to Nov 6, 2023¹⁶
Secretary and Vice PresidentMegan Kennedy Nov 6, 2023 to Nov 6, 2023¹⁷
Vice PresidentBen Ritchie Dec 22, 2023 to Dec 22, 2023¹⁸
Vice PresidentJoshua Duitz Dec 22, 2023 to Dec 22, 2023¹⁹
Chief Compliance OfficerLaura F. Woodward May 15, 2009 to May 15, 2009²⁰
Assistant TreasurerBetty T. Chang Jul 16, 2009 to Jul 16, 2009²¹
Chief Compliance OfficerCarolyn P. Haley May 15, 2007 to May 15, 2007²²
Vice PresidentHoward Y. Kim Nov 20, 2007 to Nov 20, 2007²³
Board memberChris Lavictoire Mahai Jun 11, 2026 to now²⁴
Board memberChristian Pittard Dec 18, 2025 to now²⁵
Board memberBill Maher Nov 6, 2023 to Aug 27, 2024²⁶
Board memberRose Dimartino Nov 6, 2023 to Jul 18, 2024²⁷
Board memberTodd Reit Nov 6, 2023 to Jan 4, 2024²⁸
Board memberW. Mark Watson Jun 14, 2022 to Jun 14, 2022²⁹
Board memberJeffrey Allen Bailey Aug 28, 2020 to Sep 23, 2020³⁰
Board memberThomas M. Kent Jan 18, 2018 to Jan 29, 2018³¹
Board memberElizabeth Nabel Dec 19, 2018 to Dec 19, 2018³²
Board memberUwe E. Reinhardt Jul 11, 2014 to Jul 11, 2014³³
Board memberOleg M. Pohotsky Mar 21, 2012 to Jun 30, 2014³⁴
Board memberMichael W. Bonney Dec 15, 2011 to Jun 30, 2014³⁵
Board memberWilliam S. Reardon Jun 18, 2010 to Jul 1, 2014³⁶
Board memberJain K. Rakesh Jun 29, 2007 to Jun 29, 2007³⁷
Board memberLucinda H. Stebbins Jun 22, 2006 to Jun 29, 2015³⁸
Board memberDaniel R. Omstead Oct 2, 2006 to Sep 25, 2023⁵
General counselLucia Sitar Nov 6, 2023 to Nov 6, 2023³⁹

Former names

TEKLA LIFE SCIENCES INVESTORSOct 15, 2014 to Oct 5, 2023³
H&Q LIFE SCIENCES INVESTORSDec 13, 1995 to Sep 18, 2014³

Timeline

Sep 12, 20238-K Change of auditor⁴⁰
Feb 20, 1992Founded abrdn Life Sciences Investors is founded²

Filings

163 filings to the SEC since October 2021: 1 major events, 93 insider forms, 18 large holders, 51 other. The latest 20:

The 163 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

81 open-market trades by officers, directors and large owners since October 2021: 42 buys and 39 sales. Grants, option exercises and gifts are left out.

Date	Who	Trade	Shares	Price	Value	Filing
Jul 16, 2026	Mahai Chris LaVictoireDirector	Buy	527	$19.92	$10.5K	Form 4
Dec 16, 2025	Pittard ChristianDirector	Buy	7,923	$16.88	$133.7K	Form 4
Sep 22, 2025	Saba Capital Management, L.P.10% owner	Sale	41,623	$14.14	$588.5K	Form 4
Sep 19, 2025	Saba Capital Management, L.P.10% owner	Sale	6,989	$14.10	$98.5K	Form 4
Sep 18, 2025	Saba Capital Management, L.P.10% owner	Sale	40,208	$14.07	$565.7K	Form 4
Sep 17, 2025	Saba Capital Management, L.P.10% owner	Sale	24,328	$13.99	$340.3K	Form 4
Sep 16, 2025	Saba Capital Management, L.P.10% owner	Sale	2,026	$13.99	$28.3K	Form 4
Sep 15, 2025	Saba Capital Management, L.P.10% owner	Sale	700	$14.13	$9.9K	Form 4
Sep 11, 2025	Saba Capital Management, L.P.10% owner	Sale	15,116	$14.28	$215.9K	Form 4
Sep 2, 2025	Weinstein Boaz10% owner	Sale	14,083	$14.04	$197.7K	Form 4
Aug 29, 2025	Weinstein Boaz10% owner	Sale	23,723	$13.89	$329.5K	Form 4
Aug 26, 2025	Saba Capital Management, L.P.10% owner	Sale	400	$13.83	$5.5K	Form 4
Aug 21, 2025	Saba Capital Management, L.P.10% owner	Sale	10,710	$14.07	$150.7K	Form 4
May 20, 2025	Weinstein Boaz10% owner	Sale	11,419	$12.71	$145.1K	Form 4
May 15, 2025	Weinstein Boaz10% owner	Sale	23,729	$12.08	$286.6K	Form 4
May 14, 2025	Saba Capital Management, L.P.10% owner	Sale	600	$12.04	$7.2K	Form 4
May 13, 2025	Saba Capital Management, L.P.10% owner	Sale	730	$12.28	$9.0K	Form 4
May 8, 2025	Saba Capital Management, L.P.10% owner	Sale	12,689	$11.98	$152.0K	Form 4
May 7, 2025	Saba Capital Management, L.P.10% owner	Sale	1,366	$12.19	$16.7K	Form 4
Apr 17, 2025	Weinstein Boaz10% owner	Sale	9,144	$11.78	$107.7K	Form 4

All 81 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

FIRST TRUST PORTFOLIOS LPSCHEDULE 13G/A, 5 filings Jan 21, 2022 to Oct 14, 2026⁴¹
Saba Capital Management, L.P.SCHEDULE 13D/A, 13 filings Dec 29, 2023 to Feb 23, 2026⁴²

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 83. Change is in shares since the quarter before.

Fund	Shares	Value	Share of the fund	Change
Morgan Stanley	1,771,848	$35.5M	0.0%	+200,834
Raymond James Financial Inc	689,134	$13.8M	0.0%	+27,822
LPL Financial LLC	514,161	$10.3M	0.0%	+35,359
Allspring Global Investments Holdings, LLC	455,124	$9.1M	0.0%	+92,589
Needham Investment Management LLC	443,041	$8.9M	0.3%	+13,468
Flagship Harbor Advisors, LLC	400,765	$8.0M	0.3%	+18,048
Ameriprise Financial Inc	195,451	$3.9M	0.0%	+3,690
Advisors Asset Management, Inc.	169,812	$3.4M	0.1%	+9,394
180 Wealth Advisors, LLC	152,829	$3.1M	0.3%	+3,271
Rivernorth Capital Management, LLC	150,000	$3.0M	0.1%	−48,730
Formidable Asset Management, LLC	165,243	$2.7M	0.4%	+6,858
Royal Bank Of Canada	124,679	$2.5M	0.0%	+3,439
Bank Of America Corp /de/	122,374	$2.4M	0.0%	+6,789
Blue Bell Private Wealth Management, LLC	92,899	$1.9M	0.2%	+5,003
Uhlmann Price Securities, LLC	81,518	$1.6M	0.1%	+3,661
Saba Capital Management, L.P.	78,095	$1.6M	0.0%	−869,251
1607 Capital Partners, LLC	76,387	$1.5M	0.1%	−27,676
World Investment Advisors	91,016	$1.5M	0.0%	No change
Z3 Capital Partners, LLC	72,030	$1.4M	0.3%	+4,681
Steward Partners Investment Advisory, LLC	68,721	$1.4M	0.0%	+14,408
Guggenheim Capital LLC	67,318	$1.3M	0.0%	+14,273
Stifel Financial Corp	60,855	$1.2M	0.0%	+20,549
First Trust Advisors LP	56,477	$1.1M	0.0%	−860
Invesco Ltd.	53,959	$1.1M	0.0%	+13,518
Rockefeller Capital Management L.P.	47,216	$944.8K	0.0%	+47,179

13F reports cover disclosed long positions in U.S. stocks only.

Members of Congress who traded it

3 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.

Date	Member	Trade	Amount	Vs S&P since	Filing
Oct 4, 2022	Thomas R Carper, Senate	Sale	$1,001 - $15,000	+86.0%	Report
Feb 22, 2020	Thomas R Carper, Senate	Buy	$1,001 - $15,000	−143.3%	Report
Feb 22, 2020	Thomas R Carper, Senate	Buy	$1,001 - $15,000	−143.3%	Report

Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).

SEC filer profile

How abrdn Life Sciences Investors is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

Name on EDGARabrdn Life Sciences Investors¹
CIK0000884121
Employer ID (EIN)04-3147016¹
Incorporated inMassachusetts¹
Fiscal year endsSeptember 30¹
Business address1900 Market Street, Suite 200, Philadelphia, PA 19103¹
Phone6177728515¹
On EDGAR sinceDec 13, 1995¹
Filings519 in all: 4 (92), 3 (49), DEF 14A (29), N-Q (29), NPORT-P (28), 40-17G (24), N-CSR (23), N-CSRS (23)¹
All 42 form types
N-PX (23), NSAR-A (23), NSAR-B (23), DEFA14A (22), SC 13G/A (15), SC 13D/A (12), POS EX (11), 8-K (10), CORRESP (9), N-30D (8), N-CEN (8), SCHEDULE 13D/A (7), PRE 14A (6), SC 13G (5), N-2/A (4), POS AMI (4), 40-APP/A (3), N-CSR/A (3), SC TO-I/A (3), 40-APP (2), 497 (2), EFFECT (2), N-2 (2), NO ACT (2), SC 13D (2), SCHEDULE 13G/A (2), UPLOAD (2), 40-6C (1), 497AD (1), N-CSRS/A (1), N-PX/A (1), NPORT-EX (1), SC TO-I (1), SCHEDULE 13G (1)
Latest filingsProxy statement (DEF 14A) Apr 7, 2026
Latest 8-K (8-K) Sep 12, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARabrdn Life Sciences Investors filings on SEC EDGAR
2
GLEIFabrdn Life Sciences Investors LEI record (5493007BYZPSOVVS0M04)
3
SEC EDGARabrdn Life Sciences Investors filings on SEC EDGAR
4
SEC EDGARChristian Pittard, President
5
SEC EDGARDaniel R. Omstead, President
6
SEC EDGARSharon Greenstein, Chief financial officer
7
SEC EDGARKatie Lynn Gebauer, Vice President
8
SEC EDGARMichael Marsico, Vice President
9
SEC EDGARRobert W. Hepp, Vice President
10
SEC EDGARHeather Carter Reilly, Vice President
11
SEC EDGARLoretta Tse, Vice President
12
SEC EDGARMichael Taggart, Vice President
13
SEC EDGARAshton Wilson, Vice President
14
SEC EDGARKolotioloma Silue, Vice President
15
SEC EDGARAlan R. Goodson, Vice President
16
SEC EDGARJoseph Andolina, Chief Compliance Officer & VP
17
SEC EDGARMegan Kennedy, Secretary and Vice President
18
SEC EDGARBen Ritchie, Vice President
19
SEC EDGARJoshua Duitz, Vice President
20
SEC EDGARLaura F. Woodward, Chief Compliance Officer
21
SEC EDGARBetty T. Chang, Assistant Treasurer
22
SEC EDGARCarolyn P. Haley, Chief Compliance Officer
23
SEC EDGARHoward Y. Kim, Vice President
24
SEC EDGARChris Lavictoire Mahai, Board member
25
SEC EDGARChristian Pittard, Board member
26
SEC EDGARBill Maher, Board member
27
SEC EDGARRose Dimartino, Board member
28
SEC EDGARTodd Reit, Board member
29
SEC EDGARW. Mark Watson, Board member
30
SEC EDGARJeffrey Allen Bailey, Board member
31
SEC EDGARThomas M. Kent, Board member
32
SEC EDGARElizabeth Nabel, Board member
33
SEC EDGARUwe E. Reinhardt, Board member
34
SEC EDGAROleg M. Pohotsky, Board member
35
SEC EDGARMichael W. Bonney, Board member
36
SEC EDGARWilliam S. Reardon, Board member
37
SEC EDGARJain K. Rakesh, Board member
38
SEC EDGARLucinda H. Stebbins, Board member
39
SEC EDGARLucia Sitar, General counsel
40
SEC EDGARChange of auditor
41
SEC EDGARFIRST TRUST PORTFOLIOS LP SCHEDULE 13G/A on abrdn Life Sciences Investors
42
SEC EDGARSaba Capital Management, L.P. SCHEDULE 13D/A on abrdn Life Sciences Investors